Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhananjay Chitale

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinomaYong Hannah Wen, Edi Brogi, Adnan Hasanovic, et al.
The Laryngoscope|June 18, 2016
Biological significance of genome-wide DNA methylation profiles in keloidsLamont R Jones, Joshua Greene, Kang Mei Chen, et al.
Breast Cancer Research and Treatment|August 30, 2011
Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American womenAzadeh Stark, Robert Stapp, Aditya Raghunathan, et al.
Journal of the American Society of Cytopathology|May 9, 2025
Comparison of fluorescence in situ hybridization and cytology for the accurate detection of malignant biliary strictures, with emphasis on unusual resultsBeena U Ahsan, Michelle Jin, Brian K Theisen, et al.
The Journal of Molecular Diagnostics : JMD|April 12, 2008
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expressionAllan R Li, Dhananjay Chitale, Gregory J Riely, et al.
Journal of Cutaneous Pathology|August 23, 2019
A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusionBen J Friedman, Simon Hernandez, Chelsea Fidai, et al.
Breast Cancer Research and Treatment|January 20, 2025
Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort studyThomas E Rohan, Yihong Wang, Fergus Couch, et al.
Immunologic Research|November 26, 2014
Anti-centrosome antibodies in breast cancer are the expression of autoimmunityMarie-Claire Maroun, Ofelia Olivero, Leonard Lipovich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinomaJenifer L Marks, Stephen Broderick, Qin Zhou, et al.
BMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinomaYong Hannah Wen, Edi Brogi, Adnan Hasanovic, et al.
The Laryngoscope|June 18, 2016
Biological significance of genome-wide DNA methylation profiles in keloidsLamont R Jones, Joshua Greene, Kang Mei Chen, et al.
Breast Cancer Research and Treatment|August 30, 2011
Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American womenAzadeh Stark, Robert Stapp, Aditya Raghunathan, et al.
Journal of the American Society of Cytopathology|May 9, 2025
Comparison of fluorescence in situ hybridization and cytology for the accurate detection of malignant biliary strictures, with emphasis on unusual resultsBeena U Ahsan, Michelle Jin, Brian K Theisen, et al.
The Journal of Molecular Diagnostics : JMD|April 12, 2008
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expressionAllan R Li, Dhananjay Chitale, Gregory J Riely, et al.
Journal of Cutaneous Pathology|August 23, 2019
A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusionBen J Friedman, Simon Hernandez, Chelsea Fidai, et al.
Breast Cancer Research and Treatment|January 20, 2025
Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort studyThomas E Rohan, Yihong Wang, Fergus Couch, et al.
Immunologic Research|November 26, 2014
Anti-centrosome antibodies in breast cancer are the expression of autoimmunityMarie-Claire Maroun, Ofelia Olivero, Leonard Lipovich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinomaJenifer L Marks, Stephen Broderick, Qin Zhou, et al.
BMJ Open|October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort studyThomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Pageof 6